Orna Therapeutics

Cambridge, United States

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

Aug 2022

Series B

Biotechnology Medical Pharmaceutical Therapeutics

Top Investors

Bristol-Myers SquibbMerckTaiho VenturesMPM CapitalF2 Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Orna Therapeutics

Who are Orna Therapeutics's investors?

Orna Therapeutics's investors include Bristol-Myers Squibb, Merck, Taiho Ventures, MPM Capital, F2 Ventures.

Where is Orna Therapeutics headquartered?

Orna Therapeutics is headquartered in Cambridge, United States.

What does Orna Therapeutics do?

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

What stage is Orna Therapeutics at?

Orna Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 16, 2022.

MLA

"Orna Therapeutics — Funding & Investors." VCBacked, August 16, 2022, https://www.vcbacked.co/company/orna-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Orna Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/orna-therapeutics

Wikipedia (cite web)

{{cite web |title=Orna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orna-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 16, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.